Skip to content

DR. JOREN BIESBROUCK

Active
Private limited companyfounded 2021active for 5 yearsWaterhoek(Heu) 29, 8501 Kortrijk, BelgiumKBO/BCE: BE 0775.746.612
Summary

DR. JOREN BIESBROUCK has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €76,728 and a net result of €63,172. Equity has been growing by about 43% per year since 2022. Its solvency ranks better than 63% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 14-10-2021 Normal situation
Activity
General medical practice NACE 86210and 1 other
Establishment unit
2.323.458.222 8501 Kortrijk, since 14-10-2021
Financial year end
31 December
Peppol
Reachable since 27-03-2026

Board and ownership

Board
  • Biesbrouck JorenDirector · since 13-10-2021

Financial position

96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€87,541
▲ 36.1%
Turnover
≈ €200,000
estimated
Profit
€63,172
▲ 44.4%
Equity
€76,728
▼ 8.2%
Total assets
€102,399
▼ 17.2%
Filed on 09-07-2026, 22 days before the deadline
Score breakdownraises risk2 of the last 3 accounts latelowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 5.75, cash €44,997Equity €76,728 (74.9% of total assets)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 64% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100+7
equity 74.9% of total assets
Liquidity 97=
short-term debt 14.9% · cash 43.9%
Profitability 100=
return on assets 61.7%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025highest value 10-2025: < 0.1%▼ -0.1 percentage points vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €7,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 5.75 (5.53 in 2024), above the usual 1.5. Short-term debt is 14.9% and cash 43.9% of total assets. 25.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 64% of them on solvency, 85% on liquidity, 80% on profitability and 28% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 5.75, cash €44,997
NBB · annual accounts
raises risk · 2 of the last 3 accounts late
NBB · filings
lowers risk · Equity €76,728 (74.9% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-07-2026, 22 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2025
22 days early
2024
60 days late
2023
57 days late
2022
4 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 4 accounts on average 23 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 27 August (3 of the last 4 accounts filed within 33 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Recent changes

  1. · Gazette deed Incorporation
All 6 events

Comparable companies

These companies have the same main activity as DR. JOREN BIESBROUCK: general medical practice (NACE 86210). They are comparable in size and age: total assets between €98,200 and €117,000, founded between 2021 and 2022.

CompanyTotal assetsGross margin
DR. JOREN BIESBROUCK Kortrijk€102,399€87,541
Dr.Vermeulen Marlies Huisarts Roeselare€116,775€83,952
Dokter Eline Vernieuwe Kapellen€99,438€87,467
Docteur Lambert Joanne Soumagne€102,589€88,688
DR. GIANNI VANDEN BULCKE, HUISARTS Lede€101,519€93,798
Dr Claeys Caroline Hove€112,102€90,393
Dr. Jesse Govaerts, Huisarts Antwerpen€98,156€83,113
Full comparison

Key facts about DR. JOREN BIESBROUCK

What is the company number of DR. JOREN BIESBROUCK?
The company number of DR. JOREN BIESBROUCK is 0775.746.612. The VAT number is the same number with BE in front: BE 0775.746.612.
Where is DR. JOREN BIESBROUCK based?
The registered office is at Waterhoek(Heu) 29, 8501 Kortrijk.Company details
What does DR. JOREN BIESBROUCK do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. JOREN BIESBROUCK?
The legal form of DR. JOREN BIESBROUCK is Private limited company (BV).
When was DR. JOREN BIESBROUCK founded?
DR. JOREN BIESBROUCK was founded on 14-10-2021.
Is DR. JOREN BIESBROUCK still active?
Yes, DR. JOREN BIESBROUCK is an active enterprise in the KBO register.
What is the turnover of DR. JOREN BIESBROUCK?
The turnover in financial year 2025 is ≈ €200,000. This figure is estimated from the gross margin of €87,541 and 32 comparable companies (NACE 862). It probably lies between €150,000 and €250,000.Financials
Is DR. JOREN BIESBROUCK profitable?
In financial year 2025, DR. JOREN BIESBROUCK made a profit of €63,172.
Where can I find the annual accounts of DR. JOREN BIESBROUCK?
DR. JOREN BIESBROUCK filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. JOREN BIESBROUCK due?
DR. JOREN BIESBROUCK must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.